Transaction · 0001193125-26-414164

Fisher Patrick

Fisher Patrick, PRES, GLR, reported an open-market or private sale at Orthofix Medical Inc. involving 150.000000 shares for an estimated $1416.00. Reported holdings after the transaction were 50919.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES, GLR
OFIXOrthofix Medical Inc.
Filing timeOct 05
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.29%Shares sold ÷ (holdings after + shares sold). Estimated position before: 51,069 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$9.50
Pre-filing
1mo ago -0.7%1w ago -3.6%1d ago -0.9%
Returns since
7d30d90d180d1y

OFIX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OFIX since 2026-10-05Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-414164
Common Stock
Transaction date
Oct 01, 2026
Filed Oct 05, 2026, 08:20 PM · 4d delay
Shares
150 sh
$9.44 per share
Estimated value
-$1.41k
Computed from shares × price
Holdings after
50.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, Global Limb Recon

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

  2. F2

    Includes 36,028 previously reported restricted stock units.

Original filing · 0001193125-26-414164
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OFIX